Trade Summary

4 days ago, Shetzline Michael, serving as SVP, CMO, Head-Res, Drug at Ironwood Pharmaceuticals Inc (IRWD), sold 32,582 shares at $3.73 per share, for a total transaction value of $121,586.00. Following this transaction, Shetzline Michael now holds 1,059,862 shares of IRWD.

This sale represents a 3.00% decrease in Shetzline Michael's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Ironwood Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.